BAYER A.G. (BAYZF)
Clinical trial NCT03588299 updates: 1. completion date: 2026-11-03 → 2026-09-15 2. primary completion date: 2026-11-03 → 2026-09-15
Clinical trial NCT03588299 updates: 1. completion date: 2026-11-03 → 2026-09-15 2. primary completion date: 2026-11-03 → 2026-09-15
Clinical trial NCT07587008 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-11 → 2026-05-12
Clinical trial NCT07607301 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-20 → 2026-06-04 3. completion date: 2027-03-30 → 2027-03-01 4. primary completion date: 2026-06-30 → 2026-07-01
Clinical trial NCT03363373 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-04-01 → 2026-06-01
Clinical trial NCT07587723 updates: 1. start date: 2026-05-20 → 2026-06-23 2. completion date: 2026-08-20 → 2028-09-29 3. primary completion date: 2026-08-20 → 2028-09-29
Clinical trial NCT02699957 updates: 1. completion date: 2026-01-01 → 2029-01-01 2. primary completion date: 2026-01-01 → 2029-01-01
Clinical trial NCT00148837 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: not set → 2008-12-01 3. primary completion date: not set → 2008-12-01 4. collaborators added: Pfizer
Clinical trial NCT06549348 updates: 1. completion date: 2026-06-30 → 2027-06-30 2. primary completion date: 2026-06-30 → 2027-06-30
Clinical trial NCT06510205: enrollment: 5000 → 6111 participants.
Clinical trial NCT07597928 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-12 → 2026-05-13